Proteomics

Dataset Information

0

Characterisation of VPRBP/DCAF1 kinase inhibitor analogues


ABSTRACT: Multiple myeloma is a plasma cell malignancy that is susceptible to drugs targeting protein homeostasis such as thalidomide analogues and proteasome inhibitors. Thalidomide analogues modulate the activity of DDB1/CUL4 E3-ligase complexes to perturb substrate recognition and proteasomal degradation thereof. We hypothesised that the cellular pool of DDB1/CUL4 associated factors (DCAFs) may mediate other essential plasma cell processes and offer new targets for therapeutic intervention. Utilising B32B3, a previously disclosed DCAF1 kinase inhibitor as a template, we developed a series of analogues with enhanced anti-myeloma potency.

INSTRUMENT(S):

ORGANISM(S): Homo Sapiens (human)

TISSUE(S): Blood Cell, Bone Marrow

DISEASE(S): Multiple Myeloma

SUBMITTER: Nicole Verrills  

LAB HEAD: Nikki Verrills

PROVIDER: PXD061427 | Pride | 2025-10-07

REPOSITORIES: Pride

Dataset's files

Source:
Action DRS
JJN3_18DS_Phos_1.raw Raw
JJN3_18DS_Phos_10.raw Raw
JJN3_18DS_Phos_2.raw Raw
JJN3_18DS_Prot_10.raw Raw
JJN3_18DS_Prot_2.raw Raw
Items per page:
1 - 5 of 29

Similar Datasets

2025-10-06 | GSE295791 | GEO
2025-10-06 | PXD066365 | Pride
2014-05-13 | E-GEOD-57554 | biostudies-arrayexpress
2014-05-13 | GSE57554 | GEO
2016-04-04 | E-GEOD-79830 | biostudies-arrayexpress
2020-05-06 | GSE81725 | GEO
2023-09-17 | GSE168136 | GEO
2023-09-17 | GSE158172 | GEO
2023-09-17 | GSE158171 | GEO
2024-12-21 | GSE192466 | GEO